chr15-85645841-G-C
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_007200.5(AKAP13):āc.4261G>Cā(p.Gly1421Arg) variant causes a missense change. The variant allele was found at a frequency of 0.00000125 in 1,599,872 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.0000067 ( 0 hom., cov: 32)
Exomes š: 6.9e-7 ( 0 hom. )
Consequence
AKAP13
NM_007200.5 missense
NM_007200.5 missense
Scores
4
9
6
Clinical Significance
Conservation
PhyloP100: 4.07
Genes affected
AKAP13 (HGNC:371): (A-kinase anchoring protein 13) The A-kinase anchor proteins (AKAPs) are a group of structurally diverse proteins which have the common function of binding to the regulatory subunit of protein kinase A (PKA) and confining the holoenzyme to discrete locations within the cell. This gene encodes a member of the AKAP family. Alternative splicing of this gene results in multiple transcript variants encoding different isoforms containing c-terminal dbl oncogene homology (DH) and pleckstrin homology (PH) domains. The DH domain is associated with guanine nucleotide exchange activation for the Rho/Rac family of small GTP binding proteins, resulting in the conversion of the inactive GTPase to the active form capable of transducing signals. The PH domain has multiple functions. Therefore, these isoforms function as scaffolding proteins to coordinate a Rho signaling pathway, function as protein kinase A-anchoring proteins and, in addition, enhance ligand-dependent activity of estrogen receptors alpha and beta. [provided by RefSeq, Jul 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AKAP13 | NM_007200.5 | c.4261G>C | p.Gly1421Arg | missense_variant | 10/37 | ENST00000394518.7 | NP_009131.2 | |
AKAP13 | NM_006738.6 | c.4261G>C | p.Gly1421Arg | missense_variant | 10/37 | NP_006729.4 | ||
AKAP13 | NM_001270546.1 | c.181G>C | p.Gly61Arg | missense_variant | 3/29 | NP_001257475.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AKAP13 | ENST00000394518.7 | c.4261G>C | p.Gly1421Arg | missense_variant | 10/37 | 1 | NM_007200.5 | ENSP00000378026.3 |
Frequencies
GnomAD3 genomes AF: 0.00000671 AC: 1AN: 149010Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
1
AN:
149010
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 6.89e-7 AC: 1AN: 1450862Hom.: 0 Cov.: 35 AF XY: 0.00000139 AC XY: 1AN XY: 721720
GnomAD4 exome
AF:
AC:
1
AN:
1450862
Hom.:
Cov.:
35
AF XY:
AC XY:
1
AN XY:
721720
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000671 AC: 1AN: 149010Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 72560
GnomAD4 genome
AF:
AC:
1
AN:
149010
Hom.:
Cov.:
32
AF XY:
AC XY:
0
AN XY:
72560
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 26, 2022 | The c.4261G>C (p.G1421R) alteration is located in exon 10 (coding exon 9) of the AKAP13 gene. This alteration results from a G to C substitution at nucleotide position 4261, causing the glycine (G) at amino acid position 1421 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Uncertain
CADD
Benign
DANN
Pathogenic
DEOGEN2
Benign
T;T;.;T;.;T;.
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T;T;T;T;T;T;T
M_CAP
Benign
D
MetaRNN
Uncertain
D;D;D;D;D;D;D
MetaSVM
Uncertain
D
MutationAssessor
Benign
.;L;L;.;.;.;.
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D;D;D;.;.;.;.
REVEL
Uncertain
Sift
Uncertain
D;D;D;.;.;.;.
Sift4G
Uncertain
D;D;D;D;D;D;D
Polyphen
1.0
.;D;D;.;.;.;.
Vest4
0.57, 0.53, 0.61, 0.60
MutPred
Loss of loop (P = 0.0203);Loss of loop (P = 0.0203);Loss of loop (P = 0.0203);.;.;.;.;
MVP
MPC
0.29
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at